Compromised T Cell Immunity Links Increased Cutaneous Papillomavirus Activity to Squamous Cell Carcinoma Risk.
JID Innov.
2023 Mar;3(2):100163. doi: 10.1016/j.xjidi.2022.100163. eCollection 2023 Mar. PubMed PMID:
36714811; PubMed Central PMCID:
PMC9879970.
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study.
J Am Acad Dermatol.
2023 Jan 31;. doi: 10.1016/j.jaad.2022.12.048. [Epub ahead of print] PubMed PMID:
36736626.
Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial.
Nat Med.
2023 Jan 26;. doi: 10.1038/s41591-022-02181-8. [Epub ahead of print] PubMed PMID:
36702949.
Nuclear IL-33 in fibroblasts promotes skin fibrosis.
J Invest Dermatol.
2023 Jan 25;. doi: 10.1016/j.jid.2022.12.019. [Epub ahead of print] PubMed PMID:
36708946; NIHMSID:NIHMS1870127.
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study.
medRxiv.
2023 Jan 18;. doi: 10.1101/2023.01.16.23284635. PubMed PMID:
36711758; PubMed Central PMCID:
PMC9882466.
Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells.
Front Immunol.
2022;13:1098445. doi: 10.3389/fimmu.2022.1098445. eCollection 2022. PubMed PMID:
36733396; PubMed Central PMCID:
PMC9887278.
Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression.
Res Sq.
2023 Jan 12;. doi: 10.21203/rs.3.rs-2318750/v1. PubMed PMID:
36711701; PubMed Central PMCID:
PMC9882616.
Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum.
JAMA Dermatol.
2022 Dec 21;. doi: 10.1001/jamadermatol.2022.5261. [Epub ahead of print] PubMed PMID:
36542363.
Thymic stromal lymphopoietin-stimulated CD4+ T cells induce senescence in advanced breast cancer.
Front Cell Dev Biol.
2022;10:1002692. doi: 10.3389/fcell.2022.1002692. eCollection 2022. PubMed PMID:
36467403; PubMed Central PMCID:
PMC9714463.
IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis.
J Invest Dermatol.
2022 Oct;142(10):2668-2676.e4. doi: 10.1016/j.jid.2022.03.009. Epub 2022 Mar 25. PubMed PMID:
35341735; PubMed Central PMCID:
PMC9511765.
Extracellular matrix-natural killer cell interactome: an uncharted territory in health and disease.
Curr Opin Immunol.
2022 Oct;78:102246. doi: 10.1016/j.coi.2022.102246. Epub 2022 Sep 26. Review. PubMed PMID:
36174410.
Trending Anti-E7 Serology Predicts Mortality and Recurrence of HPV-Associated Cancers of the Oropharynx.
J Oncol.
2022;2022:3107990. doi: 10.1155/2022/3107990. eCollection 2022. PubMed PMID:
36199787; PubMed Central PMCID:
PMC9529406.
Lethal Dermal Sarcoma in Immunosuppressed Patients.
Oncologist.
2022 Sep 2;27(9):e759-e761. doi: 10.1093/oncolo/oyac141. PubMed PMID:
35867136; PubMed Central PMCID:
PMC9438906.
CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation.
J Exp Med.
2022 Jul 4;219(7). doi: 10.1084/jem.20201963. Epub 2022 Jun 3. PubMed PMID:
35657353; PubMed Central PMCID:
PMC9170526.
Topical therapy for regression and melanoma prevention of congenital giant nevi.
Cell.
2022 Jun 9;185(12):2071-2085.e12. doi: 10.1016/j.cell.2022.04.025. Epub 2022 May 12. PubMed PMID:
35561684; PubMed Central PMCID:
PMC9237838.
The extracellular matrix and immunity: breaking the old barrier in cancer.
Trends Immunol.
2022 Jun;43(6):423-425. doi: 10.1016/j.it.2022.04.004. Epub 2022 May 5. PubMed PMID:
35527181.
Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment.
JID Innov.
2022 May;2(3):100104. doi: 10.1016/j.xjidi.2022.100104. eCollection 2022 May. PubMed PMID:
35310879; PubMed Central PMCID:
PMC8927816.
Thymic Stromal Lymphopoietin Induction Suppresses Lung Cancer Development.
Cancers (Basel).
2022 Apr 27;14(9). doi: 10.3390/cancers14092173. PubMed PMID:
35565302; PubMed Central PMCID:
PMC9104311.
STK11 Loss: A Novel Mechanism for Melanoma Metastasis with Therapeutic Implications.
J Invest Dermatol.
2022 Apr;142(4):1007-1009. doi: 10.1016/j.jid.2021.10.003. Epub 2022 Feb 4. PubMed PMID:
35131083.
Alarmin Cytokines as Central Regulators of Cutaneous Immunity.
Front Immunol.
2022;13:876515. doi: 10.3389/fimmu.2022.876515. eCollection 2022. Review. PubMed PMID:
35432341; PubMed Central PMCID:
PMC9005840.
Extracellular matrix proteins regulate NK cell function in peripheral tissues.
Sci Adv.
2022 Mar 18;8(11):eabk3327. doi: 10.1126/sciadv.abk3327. Epub 2022 Mar 16. PubMed PMID:
35294229; PubMed Central PMCID:
PMC8926340.
Cutaneous Squamous Cell Carcinoma: The Frontier of Cancer Immunoprevention.
Annu Rev Pathol.
2022 Jan 24;17:101-119. doi: 10.1146/annurev-pathol-042320-120056. Review. PubMed PMID:
35073167.
Supporting the Next Generation of Scientists to Lead Cancer Immunology Research.
Cancer Immunol Res.
2021 Nov;9(11):1245-1251. doi: 10.1158/2326-6066.CIR-21-0519. Epub 2021 Sep 20. PubMed PMID:
34544686; PubMed Central PMCID:
PMC9644410.
Innate Lymphoid Cells: New Targets for Cutaneous Squamous Cell Carcinoma Immunotherapy.
J Invest Dermatol.
2021 Oct;141(10):2320-2322. doi: 10.1016/j.jid.2021.04.003. PubMed PMID:
34560914.
Rejection of benign melanocytic nevi by nevus-resident CD4+ T cells.
Sci Adv.
2021 Jun;7(26). doi: 10.1126/sciadv.abg4498. Print 2021 Jun. PubMed PMID:
34162549; PubMed Central PMCID:
PMC8221625.
CD8+ T cell immunity blocks the metastasis of carcinogen-exposed breast cancer.
Sci Adv.
2021 Jun;7(25). doi: 10.1126/sciadv.abd8936. Print 2021 Jun. PubMed PMID:
34144976; PubMed Central PMCID:
PMC8213232.
Nuclear IL-33/SMAD signaling axis promotes cancer development in chronic inflammation.
EMBO J.
2021 Apr 1;40(7):e106151. doi: 10.15252/embj.2020106151. Epub 2021 Feb 22. PubMed PMID:
33616251; PubMed Central PMCID:
PMC8013835.
Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting.
J Cancer Prev.
2021 Mar 30;26(1):71-82. doi: 10.15430/JCP.2021.26.1.71. PubMed PMID:
33842408; PubMed Central PMCID:
PMC8020174.
Reply to: Beta human papillomaviruses and skin cancer.
Nature.
2020 Dec;588(7838):E22-E23. doi: 10.1038/s41586-020-3024-z. PubMed PMID:
33328662.
Human papillomavirus-positivity is associated with EREG down-regulation and promoter hypermethylation in head and neck squamous cell carcinoma.
Exp Mol Pathol.
2020 Dec;117:104549. doi: 10.1016/j.yexmp.2020.104549. Epub 2020 Sep 30. PubMed PMID:
33007298.
Enhancing the process for care delivery in a dermatology specialty clinic.
J Am Acad Dermatol.
2020 Oct;83(4):1181-1184. doi: 10.1016/j.jaad.2020.02.017. Epub 2020 Feb 14. PubMed PMID:
32068037; PubMed Central PMCID:
PMC7426239.
Divergent Roles of Epithelium-Derived Alarmins in Notch Signaling-Deficient Skin.
J Invest Dermatol.
2020 Oct;140(10):2089-2092. doi: 10.1016/j.jid.2020.02.020. Epub 2020 Mar 6. PubMed PMID:
32147504; PubMed Central PMCID:
PMC8085680.
Risk of cancer in psoriasis: study of a nationally representative sample of the US population with comparison to a single-institution cohort.
J Eur Acad Dermatol Venereol.
2020 Sep;34(9):e529-e531. doi: 10.1111/jdv.16447. Epub 2020 May 14. PubMed PMID:
32277504.
Reduction in Human Epidermal Langerhans Cells with Age Is Associated with Decline in CXCL14-Mediated Recruitment of CD14+ Monocytes.
J Invest Dermatol.
2020 Jul;140(7):1327-1334. doi: 10.1016/j.jid.2019.11.017. Epub 2019 Dec 25. PubMed PMID:
31881212; PubMed Central PMCID:
PMC8142052.
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer.
J Immunother Cancer.
2020 Jun;8(1). doi: 10.1136/jitc-2020-000796. Review. PubMed PMID:
32554617; PubMed Central PMCID:
PMC7304845.
Hypertrophic Lichen Planus with Histological Features of Squamous Cell Carcinoma Associated with Immune Checkpoint Blockade Therapy.
Oncologist.
2020 May;25(5):366-368. doi: 10.1634/theoncologist.2019-0796. Epub 2020 Feb 19. PubMed PMID:
32073194; PubMed Central PMCID:
PMC7216465.
A Case of Nivolumab-Induced Cutaneous Toxicity with Multiple Morphologies.
Dermatopathology (Basel).
2019 Oct-Dec;6(4):255-259. doi: 10.1159/000505353. eCollection 2019 Oct-Dec. PubMed PMID:
32232031; PubMed Central PMCID:
PMC7098352.
Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum.
Br J Dermatol.
2019 Nov;181(5):1095-1097. doi: 10.1111/bjd.18144. Epub 2019 Aug 7. PubMed PMID:
31102460.
Immunity to commensal papillomaviruses protects against skin cancer.
Nature.
2019 Nov;575(7783):519-522. doi: 10.1038/s41586-019-1719-9. Epub 2019 Oct 30. PubMed PMID:
31666702; PubMed Central PMCID:
PMC6872936.
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity.
Nat Biotechnol.
2019 Sep;37(9):1049-1058. doi: 10.1038/s41587-019-0192-1. Epub 2019 Jul 22. PubMed PMID:
31332324.
Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease.
JAMA Dermatol.
2019 May 1;155(5):599-603. doi: 10.1001/jamadermatol.2018.4793. PubMed PMID:
30785593; PubMed Central PMCID:
PMC6506893.
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
JCI Insight.
2019 Mar 21;4(6). doi: 10.1172/jci.insight.125476. eCollection 2019 Mar 21. PubMed PMID:
30895944; PubMed Central PMCID:
PMC6483001.
Chimeric antigen receptor costimulation domains modulate human regulatory T cell function.
JCI Insight.
2019 Mar 14;5. doi: 10.1172/jci.insight.126194. PubMed PMID:
30869654; PubMed Central PMCID:
PMC6538349.
IL-33/regulatory T cell axis triggers the development of a tumor-promoting immune environment in chronic inflammation.
Proc Natl Acad Sci U S A.
2019 Feb 12;116(7):2646-2651. doi: 10.1073/pnas.1815016116. Epub 2019 Jan 29. PubMed PMID:
30696763; PubMed Central PMCID:
PMC6377481.
Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus.
J Invest Dermatol.
2019 Jan;139(1):62-70. doi: 10.1016/j.jid.2018.06.185. Epub 2018 Jul 17. PubMed PMID:
30030152; PubMed Central PMCID:
PMC6309656.
Genetic variants in the HLA class II region associated with risk of cutaneous squamous cell carcinoma.
Cancer Immunol Immunother.
2018 Jul;67(7):1123-1133. doi: 10.1007/s00262-018-2168-2. Epub 2018 May 12. PubMed PMID:
29754218; PubMed Central PMCID:
PMC7081741.
Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
Br J Dermatol.
2017 Nov;177(5):1225-1233. doi: 10.1111/bjd.15950. Epub 2017 Oct 30. Review. PubMed PMID:
29086412; PubMed Central PMCID:
PMC5711582.
Fractional Laser Releases Tumor-Associated Antigens in Poorly Immunogenic Tumor and Induces Systemic Immunity.
Sci Rep.
2017 Oct 6;7(1):12751. doi: 10.1038/s41598-017-13095-8. PubMed PMID:
28986576; PubMed Central PMCID:
PMC5630620.
Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.
PLoS One.
2017;12(9):e0184852. doi: 10.1371/journal.pone.0184852. eCollection 2017. PubMed PMID:
28922374; PubMed Central PMCID:
PMC5602663.
Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.
Hum Immunol.
2017 Apr;78(4):327-335. doi: 10.1016/j.humimm.2017.02.002. Epub 2017 Feb 7. Review. PubMed PMID:
28185865; PubMed Central PMCID:
PMC5428079.
What would you like to do?